News report 📈 Stocks 🌍 United States ISIN US0152711091

Alexandria Real Estate Shares Slide 7.8% Following Revenue Decline

Alexandria Real Estate Equities faces investor skepticism as revenue drops 13% and 2026 guidance fails to impress, leading to a 7.8% single-day share price decline.

🕐 1 min read

4 assets impacted (Stocks). Net bias: 2 Bullish, 1 Bearish, 1 Neutral. Strongest signal: ARE ↓ 7/10 (60% confidence).

📊 Affected Assets (4)

ARE
Bearish 🤖 60%
📅 Short-term 🌍 US · Explicit

Despite beating Q2 2026 adjusted FFO, revenue fell 13% YoY and 2026 guidance midpoint was only modestly above consensus, causing a 7.8% drop and continued underperformance.

WELL
Bullish 🤖 58%
📆 Mid-term 🌍 US · Explicit

Welltower is cited as a rival that has significantly outperformed ARE with 25.7% YTD and 40.6% 52-week gains.

XLRE
Neutral 🤖 60%
📆 Mid-term 🌍 US · Explicit

ARE stock is compared against the State Street Real Estate Select Sector SPDR ETF as a sector benchmark, with ARE outperforming XLRE over three months and YTD.

EXR
Bullish 🤖 50%
📆 Mid-term 🌍 US · Explicit

EXR is referenced as another REIT that has performed even better than Welltower, suggesting strong relative gains over the past year.

🎯 Key Takeaways

  • ARE shares fell 7.8% despite an adjusted FFO beat of $1.73 per share.
  • Revenue declined 13% YoY to $662.78 million, signaling operational headwinds.
  • The REIT's 2026 FFO guidance midpoint of $6.40 sits only modestly above consensus estimates.
  • Competitors like Welltower (WELL) and EXR have significantly outperformed ARE over the past 52 weeks.

📝 Executive Summary

Alexandria Real Estate Equities (ARE) shares tumbled 7.8% after reporting a 13% year-over-year revenue decline to $662.78 million. Despite beating Q2 2026 adjusted FFO expectations, the REIT's modest guidance and operational uncertainties have left investors cautious, causing the stock to lag behind broader sector benchmarks over the past year.

❓ FAQ

Why did Alexandria Real Estate Equities stock drop despite beating FFO estimates?

The stock fell due to a 13% year-over-year revenue decline and a 2026 FFO guidance midpoint that failed to exceed market expectations significantly, alongside concerns regarding delayed capital transactions.